Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical clindamycin-benzoyl peroxide gel versus topical clindamycin lotion for mild to moderate hidradenitis suppurativa
NL-OMON48051Phase 4Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in hidradenitis suppurativa (HS) comparing Clindamycin + benzoyl peroxide gel with Clindamycin lotion (2 arms). Primary endpoint: Frequency of flares (active lesions) during 12 weeks. Planned start Jun 2019; status: not yet recruiting.
02
Drugs
clindamycinbenzoyl peroxide
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on NL-OMON48051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48051.